ATE352547T1 - Verfahren zur herstellung von eisenhydroxypyronverbindungen - Google Patents

Verfahren zur herstellung von eisenhydroxypyronverbindungen

Info

Publication number
ATE352547T1
ATE352547T1 AT03727643T AT03727643T ATE352547T1 AT E352547 T1 ATE352547 T1 AT E352547T1 AT 03727643 T AT03727643 T AT 03727643T AT 03727643 T AT03727643 T AT 03727643T AT E352547 T1 ATE352547 T1 AT E352547T1
Authority
AT
Austria
Prior art keywords
producing iron
iron hydroxypyrone
hydroxypyrone compounds
compounds
hydroxypyrone
Prior art date
Application number
AT03727643T
Other languages
English (en)
Inventor
Michael Arthur Stockham
Original Assignee
Vitra Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitra Pharmaceuticals Ltd filed Critical Vitra Pharmaceuticals Ltd
Application granted granted Critical
Publication of ATE352547T1 publication Critical patent/ATE352547T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Iron (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT03727643T 2002-05-18 2003-05-07 Verfahren zur herstellung von eisenhydroxypyronverbindungen ATE352547T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0211500.4A GB0211500D0 (en) 2002-05-18 2002-05-18 Method of forming iron hydroxypyrone compounds

Publications (1)

Publication Number Publication Date
ATE352547T1 true ATE352547T1 (de) 2007-02-15

Family

ID=9936987

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03727643T ATE352547T1 (de) 2002-05-18 2003-05-07 Verfahren zur herstellung von eisenhydroxypyronverbindungen

Country Status (11)

Country Link
US (1) US7459569B2 (de)
EP (1) EP1506183B1 (de)
AT (1) ATE352547T1 (de)
AU (1) AU2003233881A1 (de)
BE (1) BE2016C041I2 (de)
CA (1) CA2483067C (de)
DE (1) DE60311456T2 (de)
ES (1) ES2283771T3 (de)
FR (1) FR16C0033I2 (de)
GB (1) GB0211500D0 (de)
WO (1) WO2003097627A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8952061B2 (en) * 2006-08-22 2015-02-10 University Of Virginia Patent Foundation Methods and compounds regulating the erythroid response to iron deficiency
PL2125847T3 (pl) 2007-02-06 2015-12-31 Medical Res Council Materiały poli okso-hydroksy jonów metalu zmodyfikowanych ligandem, ich zastosowania i sposoby ich otrzymywania
GB0808835D0 (en) 2008-05-15 2008-06-18 Vitra Pharmaceuticals Ltd Therapeutic compositions
US8536106B2 (en) 2010-04-14 2013-09-17 Ecolab Usa Inc. Ferric hydroxycarboxylate as a builder
GB201101370D0 (en) * 2011-01-27 2011-03-09 Iron Therapeutics Holdings Ag Process
GB201404390D0 (en) * 2014-03-12 2014-04-23 Iron Therapeutics Holdings Ag Composition
US10172882B2 (en) 2014-06-22 2019-01-08 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
GB2531742B (en) * 2014-10-28 2016-10-05 Iron Therapeutics Holdings Ag Polymorphs of ferric maltol
GB201517893D0 (en) 2015-10-09 2015-11-25 Medical Res Council Methods for producing carboxylate ligand modified ferric iron hydroxide colloids
CA3019478C (en) 2016-03-31 2024-02-13 United Kingdom Research And Innovation Ferric maltol compositions for use in the treatment or prevention of cancer and tumours
AU2017242906B2 (en) * 2016-03-31 2020-11-19 Shield TX (UK) Limited Methods for producing Ferric maltol compositions from Ferrous Hydroxides
AU2017242905B2 (en) * 2016-03-31 2020-10-22 Shield TX (UK) Limited Methods for producing ferric maltol compositions from elemental iron
WO2017167963A1 (en) * 2016-03-31 2017-10-05 Medical Research Council Methods for producing ferric maltol compositions from ligand modified and ligand coated ferric hydroxides
GB202005054D0 (en) 2020-04-06 2020-05-20 Nemysis Ltd Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for Use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases
CN112574158B (zh) * 2020-12-29 2022-08-02 南京百泽医药科技有限公司 一种麦芽酚铁晶型ii及其制备方法
CN115177625A (zh) * 2022-06-28 2022-10-14 金陵药业股份有限公司 一种羧基麦芽糖铁药用组合物及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3130204A (en) * 1962-02-07 1964-04-21 Pfizer & Co C Preparation of gamma-pyrones
DE1518098A1 (de) * 1963-09-19 1969-04-10 Pfizer & Co C Verfahren zur Herstellung von Pyromekonsaeurederivaten
SE322866B (de) * 1966-12-15 1970-04-20 Astra Ab
US4018907A (en) * 1975-08-25 1977-04-19 General Foods Corporation Coloring food with iron-complexes
US4212685A (en) * 1978-12-11 1980-07-15 Lea Manufacturing Company Protective and color receptive coating for aluminum
US4279936A (en) * 1979-09-24 1981-07-21 William Underwood Company Maltol treated canned meat process
EP0094149B1 (de) * 1982-03-24 1986-09-10 National Research Development Corporation Pharmazeutische Zusammensetzungen, die Eisen-Komplexe von N-substituierten 3-Hydroxypyrid-2-on- oder -4-on-Derivaten enthalten
GR78491B (de) 1982-03-24 1984-09-27 Nat Res Dev
EP0107458B1 (de) * 1982-10-22 1987-07-29 National Research Development Corporation Pharmazeutische Zusammensetzungen
GB8308055D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8308054D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8325496D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
US4912118A (en) 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
GB8325494D0 (en) 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
USRE34313E (en) 1983-09-23 1993-07-13 National Research Development Corporation Pharmaceutical compositions
GB8329043D0 (en) * 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
GB8410290D0 (en) * 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
GB8410289D0 (en) 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
US5177068A (en) 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
GB8606913D0 (en) 1986-03-20 1986-04-23 Hider R C Treatment of sickle cell disease
JPH0367565A (ja) 1989-08-07 1991-03-22 Kansai Paint Co Ltd 鉄分強化食品
GB9209078D0 (en) 1992-04-27 1992-06-10 Hider Robert C Pharmaceutical compositions
GB9217099D0 (en) 1992-08-12 1992-09-23 British Tech Group Pharmaceutical compositions
EP0833627B1 (de) * 1995-06-10 2004-08-18 Vitra Pharmaceuticals Ltd. Eisenverbindungen, zusammensetzungen, herstellungsverfahren und verwendungen davon
GB9621273D0 (en) 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method

Also Published As

Publication number Publication date
ES2283771T3 (es) 2007-11-01
EP1506183A1 (de) 2005-02-16
CA2483067C (en) 2011-04-26
US7459569B2 (en) 2008-12-02
FR16C0033I2 (fr) 2018-01-19
BE2016C041I2 (de) 2022-08-09
FR16C0033I1 (de) 2016-09-23
WO2003097627A1 (en) 2003-11-27
CA2483067A1 (en) 2003-11-27
EP1506183B1 (de) 2007-01-24
AU2003233881A1 (en) 2003-12-02
DE60311456D1 (de) 2007-03-15
DE60311456T2 (de) 2007-11-15
GB0211500D0 (en) 2002-06-26
US20050250754A1 (en) 2005-11-10

Similar Documents

Publication Publication Date Title
BE2016C041I2 (de)
DE50005699D1 (de) Verfahren zur herstellung von thiazolidin
ATE466830T1 (de) Verfahren zur herstellung von carbonsäuresalzen
ATE316959T1 (de) Verfahren zur herstellung von 2- halogenpyridincarbonsäureamiden
ATE332189T1 (de) Verfahren zur herstellung von carbonsäuresalzen
ATE327219T1 (de) Verfahren zur herstellung von hydroxymethylthiobuttersäure
ATE370940T1 (de) Verfahren zur herstellung von (s)- glyceraldehydacetonid
ATE305919T1 (de) Verfahren zur herstellung von salzen der methallylsulfonsäure
DE69918050D1 (de) Verfahren zur herstellung von (2r, 3s)-amino-1,2-oxiran
DE50209165D1 (de) Verfahren zur herstellung von d-pantothensäure und/oder salze als zusatz zu tierfuttermitteln
ATE301634T1 (de) Verfahren zur herstellung von alpha- hydroxycarbonsäureamiden
ATE385232T1 (de) Verfahren zur herstellung von 3, 3', 6, 6'- tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'- tetraalkylen-5, 5'-dihalo-2, 2' biphenolen
ATE303356T1 (de) Verfahren zur herstellung von alkylendiamintriessigsäure
DE50208413D1 (de) Verfahren zur herstellung von d-pantothensäure und/oder deren salze als zusatz zu tierfuttermitteln
DE50209076D1 (de) Verfahren zur herstellung von d-pantothensäure und/oder deren salze als zusatz zu tierfuttermitteln
WO2002066663A3 (de) Verfahren zur herstellung von d-pantothensäure und/oder deren salze als zusatz zu tierfuttermitteln
ATE404559T1 (de) Verfahren zur herstellung von säuresalzen von gemifloxacin
ATE330932T1 (de) Verfahren zur herstellung von 3- aminoalkansäureestern
ATE517870T1 (de) Verfahren zur herstellung von alpha- aminosubstituierten carbonsäureamiden
ATE247084T1 (de) Verfahren zur herstellung von hydroxamsäuren
ATE361292T1 (de) Verfahren zur herstellung von fumagillin
ATE361275T1 (de) Verfahren zur herstellung von n-substituierten hydroxylaminen und deren salzen
ATE221727T1 (de) Verfahren zur reduzierung von die aminosäurenbiosynthese inhibierenden effekten einer auf sulphonylharnstoff basierenden verbindung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties